Welcome to our December 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 & 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐨𝐧𝐬 series, where experts across the nutraceutical industry discuss the top takeaways from 2021 and areas to watch in 2022! Tune in for our daily episodes to ensure you fuel your innovative thinking into the new year and beyond.
𝐒𝐩𝐞𝐚𝐤𝐞𝐫: Nate Erskine, Head of Market Data at CBD-Intel
To learn more about sponsorships opportunities, click here and make sure to check our media kit.
Welcome to our December reflections & prediction series. Shall we welcome today's expert?
My name is Nate Erskine from CBD Intel. My top takeaway from 2021 is that CBD has cemented its position in mass market retailers further separating great brands and suppliers from the pack due to the higher expectations and requirements these retailers place on suppliers. In 2022, I'll be watching how CBD establishes its position among different consumers. Medical formats will remain in a strong position, whereas competition from established non-CBD wellness and nutraceutical products may provide growth barriers to emerging CBD only brands as CBD becomes more of a commodity component.